141 related articles for article (PubMed ID: 34477125)
1. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
Gao W
Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
[TBL] [Abstract][Full Text] [Related]
3. IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Gao C; Duan Y; Ren Y; Zhang H; Liu J; Gao W
J Clin Lab Anal; 2021 Apr; 35(4):e23739. PubMed ID: 33704838
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of Relationship between Long Non-Coding RNA Small Nucleolar RNA Host Gene 1 and Acute Myeloid Leukemia Risk and Prognosis in Pediatric Patients].
Su W; Hong Y; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1127-1136. PubMed ID: 32798387
[TBL] [Abstract][Full Text] [Related]
5. Lnc-SOX6-1 upregulation correlates with poor risk stratification and worse treatment outcomes, and promotes cell proliferation while inhibits apoptosis in pediatric acute myeloid leukemia.
Guan X; Wen X; Xiao J; An X; Yu J; Guo Y
Int J Lab Hematol; 2019 Apr; 41(2):234-241. PubMed ID: 30624855
[TBL] [Abstract][Full Text] [Related]
6. Retraction: The
Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
Turk J Haematol; 2022 Aug; 39(3):188-195. PubMed ID: 35657175
[TBL] [Abstract][Full Text] [Related]
7. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.
Verhaak RG; Goudswaard CS; van Putten W; Bijl MA; Sanders MA; Hugens W; Uitterlinden AG; Erpelinck CA; Delwel R; Löwenberg B; Valk PJ
Blood; 2005 Dec; 106(12):3747-54. PubMed ID: 16109776
[TBL] [Abstract][Full Text] [Related]
8. The relationship of long non-coding RNA maternally expressed gene 3 with microRNA-21 and their correlation with acute ischemic stroke risk, disease severity and recurrence risk.
Liu C; Huang H; Li Y; Zhao H
Clin Neurol Neurosurg; 2021 Nov; 210():106940. PubMed ID: 34607195
[TBL] [Abstract][Full Text] [Related]
9. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
Tan Z; Zhu K; Yin Y; Luo Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients.
Moualla Y; Moassass F; Al-Halbi B; Al-Achkar W; Georgeos M; Yazigi H; Khamis A
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1387-1395. PubMed ID: 35485701
[TBL] [Abstract][Full Text] [Related]
12. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21.
Na L; Ding H; Xing E; Gao J; Liu B; Wang H; Yu J; Yu C
J Clin Lab Anal; 2020 Apr; 34(4):e23123. PubMed ID: 31907972
[TBL] [Abstract][Full Text] [Related]
13. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Kottaridis PD; Gale RE; Frew ME; Harrison G; Langabeer SE; Belton AA; Walker H; Wheatley K; Bowen DT; Burnett AK; Goldstone AH; Linch DC
Blood; 2001 Sep; 98(6):1752-9. PubMed ID: 11535508
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Ho PA; Zeng R; Alonzo TA; Gerbing RB; Miller KL; Pollard JA; Stirewalt DL; Heerema NA; Raimondi SC; Hirsch B; Franklin JL; Lange B; Meshinchi S
Blood; 2010 Aug; 116(5):702-10. PubMed ID: 20413658
[TBL] [Abstract][Full Text] [Related]
15. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of combined IDH1 and NPM1 mutations in the intermediate cytogenetic de novo acute myeloid leukemia.
Abd El-Lateef AE; Ismail MM; Almohammadi M; Gawaly AM
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):92-98. PubMed ID: 34933728
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Xu J; Zhang Y; Hu J; Ren Y; Wang H
Hematology; 2020 Dec; 25(1):79-84. PubMed ID: 32019476
[No Abstract] [Full Text] [Related]
18. [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].
Jia JS; Zhu HH; Gong LZ; Zhao T; Wang J; Jiang Q; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):398-403. PubMed ID: 31207705
[No Abstract] [Full Text] [Related]
19. Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.
He C; Wang X; Luo J; Ma Y; Yang Z
Technol Cancer Res Treat; 2020; 19():1533033820945815. PubMed ID: 32720591
[TBL] [Abstract][Full Text] [Related]
20. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
